https://www.selleckchem.com/ATM.html
This post hoc study investigated the relationship between patient response in terms of migraine headache day reduction and patient-reported outcomes of health-related quality of life (HRQoL) and disability categories. Migraine causes considerable disease-related disability and negatively impacts HRQoL of patients. Calcitonin gene-related peptide inhibitors improve these outcomes and may eliminate disability due to migraine in some patients. Analyses used data from 3 double-blind, placebo (PBO)-controlled, phase 3 studies in adults with episodic migr
Like
Comment
Share
